Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse  >  Actavis Inc    

 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2015 21 543 M
EBIT 2015 9 408 M
Net income 2015 2 986 M
Debt 2015 41 297 M
Yield 2015 0,02%
Sales 2016 24 815 M
EBIT 2016 11 792 M
Net income 2016 4 912 M
Debt 2016 30 611 M
Yield 2016 0,03%
PER 2015 61,52
PER 2016 20,79
EV / Sales 2015 7,35x
EV / Sales 2016 5,95x
Capitalization 117 083 M
More Financials
Company
Allergan Plc operates as an investment holding company.It is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand, brand generic, over-the-counter and biosimilar products.The company operates through the following segments: North... 
Sector
Pharmaceuticals
Calendar
11/04Earnings Release
More about the company
Surperformance© ratings of Actavis Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ACTAVIS INC
09/02 WILLIAM ACKMAN : Ackman's Pershing Square hedge fund drops 9.2 percent in August
09/02 Lannett to buy UCB unit to boost speciality generic drugs portfolio
08/28DJMylan's Holders Approve Perrigo Purchase
08/24DJALLERGAN : Recalls Eye Treatments Amid Safety Concerns
08/14DJMylan, Perrigo Notch Wins in Their Takeover Fight
08/10DJEndo International Beats Revenue, Earnings Targets
08/06DJAllergan Swings to Loss on Deals-Related Charges -- 2nd Update
08/06 Media stock selloff leaves Wall Street bruised
More news
Sector news : Pharmaceuticals - NEC
10:29aDJBayer Gives Green Light to Covestro IPO -- 2nd Update
09:31aDJBayer Gives Green Light to Covestro IPO -- Update
08:52a DR REDDY LABORATORIES : . Reddy’s launches MINTOP PRO TM – ProcapilT..
More sector news : Pharmaceuticals - NEC
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions